Blackhawk Capital Partners Llc. Merck & Co., Inc. Transaction History

Blackhawk Capital Partners Llc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$70.31 - $77.77 $1.62 Million - $1.79 Million	-23,044 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $31,675 - $37,310	460 Added 2.04%	23,044 $1.89 Million
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $518,825 - $575,789	7,229 Added 47.08%	22,584 $1.87 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $131,284 - $148,812	1,794 Added 13.23%	15,355 $1.19 Million
Q2 2020 Aug 04, 2020	BUY	$70.42 - $80.13 $954,965 - $1.09 Million	13,561 New	13,561 $1.04 Million
Q1 2019 May 08, 2019	SELL	$69.58 - $79.36 $1 Million - $1.14 Million	-14,410 Closed	0 $0
Q4 2018 Feb 04, 2019	SELL	$65.24 - $75.71 $207,397 - $240,682	-3,179 Reduced 18.07%	14,410 $1.1 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $25,152 - $29,578	-436 Reduced 2.42%	17,589 $1.25 Million
Q2 2018 Aug 09, 2018	SELL	$50.83 - $59.72 $98,203 - $115,379	-1,932 Reduced 9.68%	18,025 $1.09 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $993,567 - $1.15 Million	19,497 Added 4238.48%	19,957 $1.09 Million
Q4 2017 Feb 12, 2018	BUY	$51.62 - $61.64 $23,745 - $28,354	460	460 $26,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $245B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.